Friday, 12 September, 2025г.
russian english deutsch french spanish portuguese czech greek georgian chinese japanese korean indonesian turkish thai uzbek

пример: покупка автомобиля в Запорожье

 

Dr. Eng Discusses the BEACON CRC Study in BRAF-Mutated CRC

Dr. Eng Discusses the BEACON CRC Study in BRAF-Mutated CRCУ вашего броузера проблема в совместимости с HTML5
Cathy Eng, MD, professor of gastrointestinal and medical oncology, Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses the BEACON CRC study in patients with BRAF-mutated colorectal cancer.
Опубликовано: 16-04-2019
Теги: cancer oncology

Похожие видео
Dr. Lenz on Breakthrough Designation of Encorafenib, Binimetinib, and Cetuximab in BRAF+ CRC

Dr. Lenz on Breakthrough Designation of Encorafenib, Binimetinib, and Cetuximab in BRAF+ CRC01:13

Dr. Arun on Immunogenicity in Triple-Negative Breast Cancer

Dr. Arun on Immunogenicity in Triple-Negative Breast Cancer01:47

Dr. Peeters Discusses the Efficacy and Safety of Panitumumab Versus Cetuximab in Colorectal Cancer

Dr. Peeters Discusses the Efficacy and Safety of Panitumumab Versus Cetuximab in Colorectal Cancer00:57

Conducting Extended RAS Testing in Colorectal Cancer

Conducting Extended RAS Testing in Colorectal Cancer07:43

Мой аккаунт

Вход / Log In